{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "Drinking decaffeinated coffee can raise the level of L.D.L., the bad cholesterol associated with cardiovascular disease risk, new research suggests. The effect is significant, according to Dr. H. Robert Superko of the Fuqua Heart Center in Atlanta, who led the study. ''If an individual has elevated L.D.L. and wants to lower it without drugs,'' Dr. Superko said, ''a combined approach of diet, exercise, weight loss and cessation of decaffeinated coffee -- if they drink three to six cups a day -- could reduce the L.D.L. 30 percent and help avoid lifelong drug therapy.''", "headline": {"main": "With Decaf, Lose the Jitters, but Gain the Gunk?", "kicker": "VITAL SIGNS: TESTING"}, "abstract": "Dr H Robert Superko of Fuqua Heart Center leads study on impact of decaffeinated coffee on cholesterol levels; research, which was presented at American Heart Assn meeting, finds that individuals asked to drink 3 to 6 cups of decaffeinated coffee per day experienced significant increases in blood levels of LDL (S)", "print_page": "6", "word_count": 277, "_id": "4fd24e248eb7c8105d7ef89d", "snippet": "Drinking decaffeinated coffee can raise the level of L.D.L., the bad cholesterol associated with cardiovascular disease risk, new research suggests.     The effect is significant, according to Dr. H. Robert Superko of the Fuqua Heart Center in...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9E0CE4DC1431F93AA15752C1A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "SUPERKO, H ROBERT"}, {"name": "organizations", "value": "AMERICAN HEART ASSN"}, {"name": "organizations", "value": "FUQUA HEART CENTER"}, {"name": "subject", "value": "HEART"}, {"name": "subject", "value": "CAFFEINE"}, {"name": "subject", "value": "RESEARCH"}, {"name": "subject", "value": "COFFEE"}, {"name": "subject", "value": "CHOLESTEROL"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Nicholas", "rank": 1, "lastname": "Bakalar"}], "original": "By Nicholas Bakalar"}, "document_type": "article", "pub_date": "2005-11-29T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Health&Fitness", "lead_paragraph": "Despite more than a decade's worth of research showing that taking too much of a popular pain reliever can ruin the liver, the number of severe, unintentional poisonings from the drug is on the rise, a new study reports. The drug, acetaminophen, is best known under the brand name Tylenol. But many consumers don't realize that it is also found in widely varying doses in several hundred common cold remedies and combination pain relievers. These compounds include Excedrin, Midol Teen Formula, Theraflu, Alka-Seltzer Plus Cold Medicine, and NyQuil Cold and Flu, as well as other over-the-counter drugs and many prescription narcotics, like Vicodin and Percocet.", "headline": {"main": "Poisonings From a Popular Pain Reliever Are on the Rise", "kicker": "THE CONSUMER"}, "abstract": "Research shows that unintentional poisonings from acetaminophen, Tylenol pain reliever, resulting in liver damage are on rise; because drug is used within variety of over-counter medications many individuals do not know they are exceeding recommended maximum dose of 4,000 milligrams per day; consequences of acetaminophen overdose discussed; drawing (M)", "print_page": "5", "word_count": 1451, "_id": "4fd25f868eb7c8105d80f9e3", "snippet": "The number of severe, unintentional poisonings from acetaminophen is increasing.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/11/29/health/29cons.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "TYLENOL (DRUG)"}, {"name": "subject", "value": "LIVER"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "PAIN"}, {"name": "subject", "value": "ACETAMINOPHEN (DRUG)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "RESEARCH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Deborah", "rank": 1, "lastname": "FRANKLIN"}], "original": "By DEBORAH FRANKLIN"}, "document_type": "article", "pub_date": "2005-11-29T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 2, "offset": 0, "time": 53}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}